文献速递肾小球疾病

膜性肾病患者循环抗磷脂酶A2受体抗体分泌细胞的免疫表型与功能分析

A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients.
PubMed 文献 · Kidney Int Rep · 2020-08-01

该研究通过流式细胞术分析30例初治原发性膜性肾病患者、31例非免疫性慢性肾脏病及12例健康人的68种B/T细胞亚群,发现浆细胞和调节性B细胞显著升高,且浆细胞比例与血清抗PLA2R抗体水平相关;体外扩增的PLA2R特异性IgG分泌浆母细胞与血清抗体相关,TNF-α为唯一显著升高的细胞因子。

要点

  • 膜性肾病患者循环浆细胞和调节性B细胞显著高于非免疫性CKD和健康对照。
  • 循环浆细胞比例与血清抗PLA2R抗体水平及疾病活动度相关。
  • 体外扩增的PLA2R特异性IgG分泌浆母细胞与血清抗PLA2R抗体相关。

核心结论

  • 膜性肾病患者循环中存在自身反应性浆细胞,可作为治疗靶点和疾病活动度的候选生物标志物。

研究设计与样本

  • 研究纳入30例未接受免疫抑制治疗的膜性肾病患者、31例非免疫性慢性肾脏病和12例健康人,用流式细胞术分析68种B/T细胞亚群,并检测19种血清细胞因子、体外PLA2R特异性IgG分泌及噬菌体免疫沉淀测序。

主要发现

  • 调整多重检验后,膜性肾病患者浆细胞和调节性B细胞显著高于两个对照组(P < 0.05)。
  • 循环浆细胞百分比与血清抗PLA2R抗体水平相关(P = 0.042),并与疾病活动度相关。
  • 体外扩增的PLA2R特异性IgG分泌浆母细胞与血清抗PLA2R IgG抗体相关(P < 0.001)。
  • TNF-α是膜性肾病患者唯一显著升高的细胞因子(P < 0.05)。
  • 各组间自身抗体和抗病毒抗体谱无显著差异。

临床怎么用

  • 循环浆细胞和PLA2R特异性浆母细胞有望作为评估膜性肾病疾病活动度的生物标志物。
  • 针对自身反应性浆细胞的治疗可能成为膜性肾病的新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Primary membranous nephropathy (MN) is characterized by the presence of antipodocyte antibodies, but studies describing phenotypic and functional abnormalities in circulating lymphocytes are limited. METHODS: We analyzed 68 different B- and T-cell subsets using flow cytometry in 30 MN patients (before initiating immunosuppression) compared with 31 patients with non-immune-mediated chronic kidney disease (CKD) and 12 healthy individuals. We also measured 19 serum cytokines in MN patients and in healthy controls. Lastly, we quantified the ex vivo production of phospholipase A2 receptor (PLA2R)-specific IgG by plasmablasts (measuring antibodies in culture supernatants and by the newly developed FluoroSpot assay [AutoImmun Diagnostika, Strasberg, Germany]) and assessed the circulating antibody repertoire by phage immunoprecipitation sequencing (PhIP-Seq). RESULTS: After adjusting for multiple testing, plasma cells and regulatory B cells (BREG) were significantly higher (P < 0.05) in MN patients compared with both control groups. The percentages of circulating plasma cells correlated with serum anti-PLA2R antibody levels (P = 0.042) and were associated with disease activity. Ex vivo-expanded PLA2R-specific IgG-producing plasmablasts generated from circulating PLA2R-specific memory B cells (mBCs) correlated with serum anti-PLA2R IgG antibodies (P < 0.001) in MN patients. Tumor necrosis factor-α (TNF-α) was the only significantly increased cytokine in MN patients (P < 0.05), whereas there was no significant difference across study groups in the autoantibody and antiviral antibody repertoire. CONCLUSION: This extensive phenotypic and functional immune characterization shows that autoreactive plasma cells are present in the circulation of MN patients, providing a new therapeutic target and a candidate biomarker of disease activity.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Cantarelli C, Jarque M, Angeletti A, et al. A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients. Kidney Int Rep. 2020. PMID: 33102969. doi:10.1016/j.ekir.2020.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。